HH
HBM Healthcare Investments AG
Venture CapitalActiveHBM Healthcare Investments finances companies related to human medicine, biotechnology, medical technology, and diagnostics sectors.
131
Investments
4
Exits
$2.1B
AUM
3.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for HBM Healthcare Investments AG.
Investment Thesis & Strategy
HBM Healthcare Investments invests in various stages of companies within the human medicine, biotechnology, medical technology, and diagnostics sectors. They seek to finance companies with innovative solutions in healthcare.
Investment Activity
Deals per year over the last 16 years
1
20062
20071
20080
20091
20100
20110
20120
20130
20143
20150
20162
20171
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 131 companies
A
Aurion Biotech
Biotech · Growth, 2021
T
TCR2 Therapeutics
Biotech · Growth, 2018
B
Biohaven Pharmaceutical
Biotech · Growth, 2017
C
Calliditas Therapeutics
Biotech · Growth, 2017
G
GenSight Biologics
Biotech · Growth, 2015
O
ObsEva
Biotech · Growth, 2015
A
ADC Therapeutics
Biotech · Growth, 2015
A
Argenx
Biotech · Growth, 2010
P
Polyphor
Biotech · Growth, 2008
A
Affimed
Biotech · Growth, 2007
M
Molecular Partners
Biotech · Growth, 2007
I
Incyte
Biotech · Growth, 2006
Notable Exits
CompanyTypeYearValue / Acquirer
ObsEvaAcquisition2023—
IdorsiaIPO2017—
Auris MedicalIPO2014—
ArpidaAcquisition2008—
Frequently Asked Questions
HBM Healthcare Investments AG focuses on Series A, Series B, Series C+ stage investments.